← FDA Drug Approvals (Drugs@FDA)

EFAVIRENZ

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: PHARMACARE LTD · Approved 2017-05-19

Drug application

FDA Application #

ANDA207895

Application type

Abbreviated New Drug Application (Generic)

Brand name

EFAVIRENZ

Generic name

Efavirenz

Active ingredients

EFAVIRENZ

Dosage form

TABLET

Route

ORAL

Marketing status

None (Tentative Approval)

Sponsor

PHARMACARE LTD

First approval

2017-05-19

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown